Thanks to private funding, 100% of every dollar donated to The Lustgarten Foundation goes directly to pancreatic cancer research.

Press Releases

Read current and past press releases outlining the latest news and announcements from The Lustgarten Foundaiton.

2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016

2017 Press Releases


LUSTGARTEN FOUNDATION FUNDED RESEARCH FINDS T CELL PROXIMITY TO PANCREATIC CANCER CELLS CORRELATES WITH INCREASED PATIENT SURVIVAL

BETHPAGE, N.Y., May 1, 2017 Findings reinforce the importance of immunotherapy research. Lustgarten Foundation’s funded research found that spatial distribution of cytotoxic T-cells in proximity to pancreatic ductal adenocarcinoma (PDAC) cancer cells correlates with increased patient survival. Desmoplasia, the growth of fibrous or connective tissue, causes dense fibrosis around the tumor making it difficult to treat the cancer. It has been hypothesized that desmoplastic materials create an impenetrable environment and drive T lymphocytes away from cancer cells, which are necessary for the body’s immune response.  Read More...

 

Newly Discovered Mutations Impair Key Cell Pathways in Pancreatic Cancer

Cold Spring Harbor, NY — By closely studying a part of the human genome that has not yet been carefully scrutinized in studies of cancer, researchers at Cold Spring Harbor Laboratory (CSHL) have found important new clues to the development of pancreatic cancer.The researchers looked exclusively at small segments of DNA called promoters in samples of tumors taken from 308 pancreatic cancer patients. Promoters are typically located adjacent to genes that they have a role in regulating. An activated promoter can, for example, switch “on” the gene it sits next to. One of many causes of cancer are genes that stay “on” for too long, bypassing natural signals to shut down. This is one way cancers grow out of control. Read More...

2016 Press Releases


16TH ANNUAL HOLIDAY ROCK & ROLL BASH RAISES $1.2 MILLION FOR THE LUSTGARTEN FOUNDATION

BETHPAGE, NY, December 15, 2016 – On Wednesday evening, December 14, The Madison Square Garden Company (NYSE: MSG) and AMC Networks (NASDAQ: AMCX) hosted the 16th Annual Holiday Rock & Roll Bash to benefit the Lustgarten Foundation, the nation’s largest private nonprofit funder of pancreatic cancer research. The Bash is the Foundation’s premier fundraising event, and this year, raised $1.2 million. Due to the support of private funding, 100 percent of every dollar raised goes directly to pancreatic cancer research.  Read More...

Stand Up To Cancer Returns For Fifth Live Roadblock Telecast Friday, September 9th - Bradley Cooper to Executive Produce With Award-Winning Team at Done + Dusted


LOS ANGELES – JUNE 16, 2016 –The Hollywood community is once again uniting to support Stand Up To Cancer (SU2C), a program of the Entertainment Industry Foundation (EIF), which will stage its fifth biennial televised fundraising special on Friday, Sept. 9 (8:00 – 9:00 PM ET/PT / 7:00 PM CT). Academy Award-nominated actor and founder of the Charles J Cooper Patient Support Fund, Bradley Cooper, will serve as executive producer along with renowned live, large-scale event producers Done + Dusted, working with Stand Up To Cancer’s production team. Additional stars and performers will be announced in the coming weeks. Read More...

The Lustgarten Foundation Joins More Than 40 Global Pancreatic Cancer Organizations At Inaugural Meeting

World Pancreatic Cancer Coalition Aims to Raise Unprecedented Awareness for a Disease with the Lowest Survival Rate of Any Major Cancer
The first-ever World Pancreatic Cancer Coalition (WPCC) will gather for its inaugural meeting in Orlando, Fla., on May 11, 2016, bringing together more than 60 individuals representing 40 pancreatic cancer advocacy groups from around the globe. The Coalition’s goal is to drive transformational change for those affected by pancreatic cancer. Read More...
 

 

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303